Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 255-449-7 | CAS number: 41583-09-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Oral: Melamine phosphate is of low acute oral toxicity as determined in a GLP and OECD-guideline compliant study with rats. No indication of toxicity was observed at the limit dose of 2000 mg/kg bw.
Inhalation: There is no study available with melamine phosphate but with melamine. Absence of systemic toxicity upon acute inhalation is derived from a GLP and OECD guideline compliant study with melamine tested with an aerosol of 5.19 g/m³.
Dermal: As the substance is strongly charged and has a log POW of -3, high dermal absorption is not expected.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2001 - 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Specific details on test material used for the study:
- Molecular formula: C3H6N6H3O4P
Molecular weight: 224
CAS number: 41583-09-9
Description: White solid
Batch: Not indicated
Purity: >98%
Test substance storage: At room temperature in the dark
Stability under storage conditions: Not indicated
Specific Gravity: 1.74
Stability in vehicle: At least 96 h in 1% Aq. Carboxymethyl cellulose - Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Rat, Wistar strain Cri:(WI) BR (outbred, SPF-Quality). Recognised by intemational guidelines as the recommended test system (e.g. OECD, EC). Source: Charies River Deutschland, Sulzfeld, Germany.
Young adult animals (approx. 6 weeks old) were selected. Body weight variation did not exceed +/- 20% of the sex mean.
Identification by earmark
A controlled environment was maintained in the room with optimal conditions considered as being approximately 15 air changes per hour, a temperature of 21±3°C, a relative humidity of 30-70% and 12 hours artificial fluorescent light and 12 hours dark per day. Temporary deviations from the maximum level for relative humidity (with a maximum of 20%) occurred which might have been caused by cleaning procedures in the room. Based on laboratory historical data these deviations were considered not to have affected the study integrity.
Group housing of 3 animals per sex per cage in labelled Macrolon cages (type IV; height 15 cm) containing purified sawdust as bedding material.
Acclimatisation period was at least 5 days before start of treatment under laboratory conditions.
Free access to diet and water, fasting period 20h - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 3 males and 3 females
- Control animals:
- no
- Details on study design:
- Mortality/Viability: Twice daily.
Body weights: Days 1 (pre-administration), 8 and 15.
Clinical signs:
At periodic intervals on the day of dosing (day 1) and once daily thereafter, until day 15. The symptoms were graded according to fixed scales and the time of onset, degree and duration were recorded:
Maximum grade 4: grading slight (1) to very severe (4)
Maximum grade 3: grading slight (1) to severe (3)
Maximum grade 1: presence is scored (1).
Necropsy: At the end of the observation period, all animals were sacrificed by asphyxiation using an oxygen/carbon dioxide procedure and subjected to necropsy. Descriptions of all internal macroscopic abnormalities were recorded. - Statistics:
- No statistical analysis was performed (The method used is not intended to allow the calculation of a precise LD50 value).
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 2 000 mg/kg bw
- Remarks on result:
- other: No clinical signs, no effects on body weight and no findings upon necropsy.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- none
- Clinical signs:
- other: none
- Gross pathology:
- no findings
- Other findings:
- none
- Interpretation of results:
- GHS criteria not met
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- GLP study according OECD TG 423
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- For Read-Across Justification please refer to section 13.
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5 190 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: CAS 108-78-1
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating conc.
- Value:
- 5 190 mg/m³ air
- Quality of whole database:
- GLP study according OECD TG 403 (Read Across)
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Oral
In an acute oral toxicity study, melamine phosphate was administered by oral gavage to three Wistar rats of each sex at 2000 mg/kg body weight. The study was performed under GLP and according to OECD testing guideline 423. Animals were subjected to daily observations and weekly determination of body weight. Macroscopic examination was performed after terminal sacrifice on day 15. No mortality occurred and no clinical signs of systemic toxicity were noted. The mean body weight gain shown by the animals over the study period was considered to be normal. No abnormalities were found at macroscopic post mortem examination of the animals. The study is adequate in design and reporting to fulfil the criteria as key study (BASF SE 335183, 2002)
Inhalation
Melamine phosphate was not tested for acute inhalation toxicity. It is acceptable to derive the systemic toxicity from experimental data of melamine since both melamine and its phosphate salt have a high solubility in water and a log POW of less than 1 and phosphate is an abundant in cells and body fluids. In addition, the higher molecular weight of melamine phosphate compared to melamine gives a safety margin.
The acute inhalation toxicity of Melamine was observed by nose-only exposure of one group of five male and five female rats to a test atmosphere containing the limit concentration of 5.19 +/- 0.45 g test item per m³ for a single 4-hour period. The Mass Median Aerodynamic Diameter was 6.6 µm. After exposure the animals were observed for 2 weeks. Clinical examinations resulted in changes in breathing pattern in all animals during the exposure to the test item and in blepharospasm in two females shortly after the administration. From day 1 onwards until the end of the experiment on day 14 no abnormalities were observed in the animals. Overall body weight gain was considered to be normal and no mortality occurred. On day 14 after the administration all animals were necropsied. Abnormalities at necropsy consisted of lung changes (petechiae, discolouration and white spots) in all animals and thymic changes (unilateral red thymus) in one male. It was concluded that the 4 -hour LC50 value of Melamine was higher than 5.19 g/m³ for both sexes under the present test conditions (DSM N.V. V98.420, 1998).
Dermal
According to ECHA guidance, an acute dermal toxicity study is not necessary. Since melamine does not undergo metabolism (Mast 1983), the acute dermal hazard can be derived from oral data unless high dermal absorption is expected. As the substance is strongly charged and has a log POW of -3, high dermal absorption is not expected. In the absence of acute oral toxicity of melamine phosphate, the LD50 for acute dermal toxicity is expected to be above 2000 mg/kg bw.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes. As a result the substance is not considered to be classified for acute oral, dermal or inhalative toxicity under Regulation (EC) No. 1272/2008, as amended for the fourteenth time in Regulation (EU) No. 2020/217.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.